Target intelligence / Profile preview

Staphylococcus aureus accessory gene regulator autoinducing peptide (AIP)

Target
AIP
Molecular classification
Other
01

Overview

The Staphylococcus aureus accessory gene regulator autoinducing peptide (AIP) is a macrocyclic thiolactone peptide that serves as the primary signaling molecule for the agr quorum-sensing system (Novick & Geisinger, 2008). Produced from the precursor protein AgrD and processed by the membrane protease AgrB, AIP is secreted into the extracellular environment to monitor bacterial population density (Thoendel et al., 2011). Upon reaching a critical threshold, AIP binds to the extracellular loops of its cognate transmembrane sensor kinase, AgrC, initiating a signal transduction cascade that activates the response regulator AgrA (Wang & Muir, 2016). This activation leads to a massive shift in the staphylococcal transcriptome, upregulating the production of secreted toxins, such as alpha-hemolysin and phenol-soluble modulins, while downregulating surface-associated colonization factors (Otto, 2014). Because the agr system is essential for the pathogenesis of acute S. aureus infections, AIP and its receptor AgrC are major targets for anti-virulence drug development. Therapeutic strategies include the use of synthetic AIP analogs or small molecules like Solonamide B to competitively inhibit AIP-AgrC binding, thereby “quenching” the quorum-sensing response and reducing tissue damage without exerting direct bactericidal pressure (Nielsen et al., 2014).

Other names
Agr autoinducerAutoinducing peptideStaphylococcal AIPThiolactone signaling peptide
02

Mechanism of action

Competitive inhibition of the AgrC sensor kinase receptor to prevent the activation of the accessory gene regulator (agr) quorum-sensing system.

03

Biological functions

Signal transductionOther
04

Disease associations

Infection
05

Safety considerations

Strain-specific interference and cross-group activationPotential for promoting biofilm persistenceLimited efficacy as a monotherapy
06

Interacting drugs

Solonamide B

4 more in the full profile.

07

Biomarkers

RNAIII expression levelsAlpha-hemolysin (Hla) productionAgrA phosphorylation state

Beyond the preview

Go deeper on Staphylococcus aureus accessory gene regulator autoinducing peptide (AIP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Staphylococcus aureus accessory gene regulator autoinducing peptide (AIP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call